Erythrasma: A report of nine men successfully managed with mupirocin 2% ointment monotherapy
Greywal, T.; Cohen, P.R.
Dermatology Online Journal 23(5)
2017
ISSN/ISBN: 1087-2108 PMID: 28537862 Document Number: 692954
Erythrasma is a benign dermatosis that typically occurs on intertriginous skin. We describe a series of nine men with erythrasma that were successfully treated with mupirocin 2% ointment monotherapy. We reviewed PubMed for the following terms: erythrasma, mupirocin, ointment, treatment. We also reviewed papers containing these terms and their references. Complete resolution of erythrasma occurred following monotherapy with twice daily application of mupirocin 2% ointment. Several topical and oral treatments are available to successfully manage erythrasma. Our series of patients with erythrasma experienced resolution with mupirocin 2% ointment treatment within 2 to 4 weeks of therapy. Monotherapy with mupirocin 2% ointment should be considered as a primary treatment alternative for erythrasma.